Medications
Erlotirel Film-Coated Tablets
ErlotiRel (Erlotinib) Film-coated Tablet (100mg or 150mg) is an antineoplastic agent, specifically functioning as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It inhibits the intracellular phosphorylation of HER1/EGFR receptor, resulting in cell stasis and/or death. It is administered orally.
Approved Indications:
-
First-line treatment of patients with locally advanced or metastatic non-small cell lung cancer with EGFR activating mutations. -
Switch maintenance treatment in patients with locally advanced or metastatic NSCLC with EGFR activating mutations and stable disease after first-line chemotherapy. -
Treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. -
In combination with gemcitabine, for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.